^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    fluoxymesterone

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    Testosterone agonist
    Related drugs:
    Associations

    News

    Trials
    11ms
    Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone. (PubMed, Breast Cancer Res)
    Our findings suggest that an AR-agonist may be of value in AR-enriched, ER-enriched breast cancers and should be studied in future trials because of the availability of new, more tolerable AR-agonists.
    Clinical • Journal
    |
    ER (Estrogen receptor) • AR (Androgen receptor)
    |
    ER positive
    |
    tamoxifen • fluoxymesterone